What's new? Log in Free sign up

Filing search / Fate Therapeutics, Inc. / "Responsible"

Search information

Fate Therapeutics, Inc.

Companies

"Responsible"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

176 results

Newest first Best match first

FATE Fate Therapeutics, Inc.

as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls

5 Mar 25

4:03pm

FATE Fate Therapeutics, Inc.

be achieved. Under our arrangement with Ono and any future corporate arrangements that we may form, our corporate collaborators may be responsible for: electing … in accordance with the applicable protocol, legal and regulatory requirements and scientific standards. We are responsible for complying, and we

5 Mar 25

4:03pm

FATE Fate Therapeutics, Inc.

person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell securities. You are responsible … responsible for ensuring compliance with the Insider Trading Policy and the Trading Procedures by all of my “Affiliated Persons.” I also understand

5 Mar 25

4:03pm

FATE Fate Therapeutics, Inc.

Departure of Directors or Certain Officers

furnish, at Advisor’s own expense, the materials, equipment, supplies, and other resources necessary to perform the Services and shall be responsible … will be responsible for any noncompliance by them. Advisor agrees to indemnify Company from any and all claims, damages, liability, settlement, attorneys’ fees

FATE Fate Therapeutics, Inc.

Quarterly report

to extend the sublease term. Under the sublease agreement, rent is subject to scheduled annual increases and the subtenant is responsible for certain … milestones be achieved. Under our arrangement with Ono and any future corporate arrangements that we may form, our corporate collaborators may be responsible

12 Nov 24

4:03pm

Quarterly report

12 Nov 24

4:03pm

1k9z74l 4yot3d5

Quarterly report

13 Aug 24

4:08pm

Quarterly report

13 Aug 24

4:08pm

l5olk8 vefwo0tok

Quarterly report

9 May 24

4:05pm

Quarterly report

9 May 24

4:05pm

2ugwofxn33bzac8d996

Quarterly report

9 May 24

4:05pm

Definitive proxy

26 Apr 24

4:06pm

Preliminary proxy

16 Apr 24

4:05pm

Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement

Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement

Prospectus supplement for primary offering

26 Feb 24

4:10pm

26 Feb 24

4:10pm

26 Feb 24

4:10pm

26 Feb 24

4:10pm

Prev
1
2
3
4
5
...
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.